ORIC PHARMACEUTICALS, INC. (ORIC)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mueller Industries, Inc. Announces Retirement of Gary S. Gladstein from the Board of Directors Effective December 31, 2026
Birchtech Announces Results of Voting from Annual Meeting of Stockholders
Uranium Royalty Appoints New Directors to the Board
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Penske Automotive Group, Inc. (PAG) Investigation: Halper Sadeh LLC Investigates Whether the Proposed Buyout of Penske Automotive Group, Inc. for $210.00 Per Share Is Fair to Shareholders
Lemonade to Present at the Oppenheimer 29th Annual Technology, Internet & Communications Conference
Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date
First Horizon Recognized on Memphis Business Journals "Best Places to Work in Memphis" List